510(k) K231832
K231832 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Myoglobin". The FDA issued a decision of Substantially Equivalent on September 18, 2023. The device falls under product code DDR (Myoglobin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5680. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 18, 2023
- Date Received
- June 22, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Myoglobin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5680
- Review Panel
- IM
- Submission Type